Skip to Main Content

Paper Details

Pre-and post-HSCT use of TKI therapy for fusion-driven B-ALL: A case series of five pediatric, adolescent and young adult patients.
Cancer Rep (Hoboken)
1
2023
ABL1, B, B-ALL, B-ALL blast, BCR, CML, Ph, Ph+B-ALL, Ph-, Ph-like B-ALL, Ph-like fusions, Philadelphia, Philadelphia chromosome (Ph+) B cell, Philadelphia chromosome (Ph+) B cell acute lymphoblastic leukemia, adult, fusion, hematopoietic stem cell, patients, tyrosine, tyrosine kinase
Author NameAffiliation
E Alejandro Sweet-CorderoBenioff Children's Hospitals, University of California san francisco
E Alejandro Sweet-CorderoBenioff Children's Hospitals, University of California san francisco
  • 1 - 2

Datasets

Release 1.2